MedPath

Soluble VE-cadherin in Prediction and Diagnosis of Early Postoperative Hypoxemia After Cardiopulmonary Bypass

Not Applicable
Completed
Conditions
ARDS
Lung Injury, Acute
Hypoxemia
Cardiopulmonary Bypass
Registration Number
NCT05647382
Lead Sponsor
Zhuan Zhang
Brief Summary

More than 2 million patients worldwide receive heart surgery every year, majority of these surgical patients will undergo cardiopulmonary bypass. However, the incidence of postoperative acute lung injury due to cardiopulmonary bypass is still as high as 20% to 35%. According to clinical experience, the earlier lung damage is detected, the more successful the treatment will be. On the basis of traditional detection, the investigators found a new indicator, serum soluble vascular endothelial-cadherin, which are easy to obtain and have certain specificity. Importantly, they can predict postoperative acute lung injury within 1 hour after cardiac surgery. It is meaningful that this indicator can provide clinicians with early decision-making advice and immediate treatment for patients who may be at risk.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Age ≥ 18 years;
  • Underwent cardiac surgery using CPB technology.
Exclusion Criteria
  • Patient's lack of consent to participate;
  • Presence of abnormal liver, kidney or other organ function;
  • Pulmonary inflammation, chronic obstructive pulmonary disease or tumors;
  • Underwent cardiac surgery without CPB technology;
  • Postoperative need for extracorporeal membrane oxygenation support.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
PaO2/FiO2 ratioDay 1 after CPB, Day 2 after CPB

The ratio of inspiratory oxygen fraction to oxygen pressure (PaO2/FiO2) was calculated

lung-injury scoresDay 1 after CPB, Day 2 after CPB

A structured tutorial was used to establish consensus in the interpretation of radiographs for radiographic lung-injury scores, range from 0 to 4.

0: No alveolar consolidation; 1: Alveolar consolidation confined to 1 quadrant; 2: Alveolar consolidation confined to 2 quadrants 3: Alveolar consolidation confined to 3 quadrants; 4: Alveolar consolidation in all 4 quadrants.

The higher scores mean a worse outcome.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

the Affiliated Hospital of Yangzhou University

🇨🇳

Yangzhou, Jiangsu, China

the Affiliated Hospital of Yangzhou University
🇨🇳Yangzhou, Jiangsu, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.